Telomerase: a therapeutic target for the third millennium?

Lavelle, F; Riou, J F; Laoui, A; Mailliet, P

Lavelle, F; Riou, J F; Laoui, A; Mailliet, P.

Affiliation

Lavelle F; Centre de Recherche de Vitry-Alfortvide, Rhône-Poulenc Rorer, 94403, Vitry-sur-Seine, France. francois.lavelle@wanadoo.fr

Crit Rev Oncol Hematol ; 34(2): 111-26, 2000 May.

Article in En | MEDLINE | ID: mdl-10799836

Subject(s)

Antineoplastic Agents/metabolism; Enzyme Inhibitors/therapeutic use; Telomerase/antagonists & inhibitors; Animals; Antineoplastic Agents/pharmacology; Cell Division/drug effects; Drug Design; Enzyme Inhibitors/metabolism; Enzyme Inhibitors/pharmacology; Forecasting; Humans; Molecular Structure; Telomerase/genetics; Telomerase/metabolism; Telomere/chemistry; Telomere/metabolism

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Telomerase / Enzyme Inhibitors / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Crit Rev Oncol Hematol Year: 2000 Document type: Article

Search on Google

XML

PubMed Links